Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018329 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01018329 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 10 participants.
The verdict
NCT01018329, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as magnetic resonance imaging, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying magnetic resonance imaging in response to radiation therapy in patients with high grade glioma.
Interventions
- PROCEDURE Magnetic Resonance Imaging
- PROCEDURE Magnetic Resonance Spectroscopic Imaging
- PROCEDURE Diffusion Tensor Imaging
- PROCEDURE Dynamic Contract-Enhanced magnetic resonance imaging
- PROCEDURE Diffusion-weighted magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018329
The ClinicalTrials.gov registry entry for NCT01018329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT01018329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018329 about?
NCT01018329 is a clinical study titled "Magnetic Resonance Imaging in Evaluating Response to RadiationTherapy in Patients With High Grade Glioma". RATIONALE: Diagnostic procedures, such as magnetic resonance imaging, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying magnetic resonance imaging in response to radiation therapy in patients with high grade glioma.
What is the current status of trial NCT01018329?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2009-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01018329?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Magnetic Resonance Spectroscopic Imaging (PROCEDURE), Diffusion Tensor Imaging (PROCEDURE), Dynamic Contract-Enhanced magnetic resonance imaging (PROCEDURE), Diffusion-weighted magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01018329?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.